Advisor Group’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$165K Sell
3,557
-1,738
-33% -$75.3K ﹤0.01% 2547
2019
Q3
$215K Sell
5,295
-2,333
-31% -$101K ﹤0.01% 2272
2019
Q2
$367K Sell
7,628
-1,189
-13% -$62.5K ﹤0.01% 1836
2019
Q1
$553K Sell
8,817
-16,285
-65% -$1.12M ﹤0.01% 1516
2018
Q4
$1.5M Buy
25,102
+18,053
+256% +$1.08M 0.01% 747
2018
Q3
$454K Buy
7,049
+4,355
+162% +$243K ﹤0.01% 1541
2018
Q2
$122K Sell
2,694
-179
-6% -$7.14K ﹤0.01% 2367
2018
Q1
$89K Sell
2,873
-20,580
-88% -$677K ﹤0.01% 2651
2017
Q4
$702K Sell
23,453
-298
-1% -$8.63K 0.01% 1108
2017
Q3
$784K Buy
23,751
+3,754
+19% +$130K 0.01% 942
2017
Q2
$669K Buy
19,997
+6,711
+51% +$200K 0.01% 968
2017
Q1
$384K Buy
13,286
+13,086
+6,543% +$324K 0.01% 1230
2016
Q4
$4K Buy
+200
New +$3.91K ﹤0.01% 4081

Other funds holding BEAT

Advisor Group's BEAT Position: Q4 2019 in Review

Advisor Group reduced its BioTelemetry, Inc. (BEAT) stake by 33% in Q4 2019, selling an estimated $75.3K and leaving 3,557 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #2547.

Advisor Group first reported a position in BEAT in Q4 2016 and has held it in 13 quarters since. The position peaked at $1.5M in Q4 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • Advisor Group held 3,557 shares of BioTelemetry, Inc. worth $165K as of Q4 2019.
  • Advisor Group sold 1,738 BioTelemetry, Inc. shares in Q4 2019, an estimated $75.3K.
  • BioTelemetry, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2547 holding.
  • Advisor Group first reported a position in BioTelemetry, Inc. in Q4 2016 and has held it in 13 quarters since.
  • Advisor Group's BioTelemetry, Inc. position peaked at $1.5M in Q4 2018.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.